Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate
Clinical trial NCT04136353 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04136353
- Sponsor
- University of Sydney
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-31
- Primary completion
- 2028-01-31
- Enrollment
- 1100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.